Sakai A, Langille R M
Department of Anatomy, Faculty of Medicine, University of Ottawa, Ontario, Canada.
Differentiation. 1992 Dec;52(1):19-32. doi: 10.1111/j.1432-0436.1992.tb00496.x.
Retinoic acid (RA) is well known to be a potent teratogen and induces a variety of facial defects in vivo, but at concentration levels lower than those that cause facial defects, RA seems to play an important role in normal facial development. In a previous study, we demonstrated the ability of RA to stimulate chondrogenesis in vitro in HH stage 23/24 chick mandibular (MND) but not frontonasal (FNP) mesenchyme cultured in a serum-free medium. The present study furthers these results by examining the effects of RA on chondrogenesis of chick facial mesenchyme at earlier embryonic stages and the effects on cell proliferation and synthesis of specific extracellular matrix macromolecules at stage 23/24. MND and FNP cells were cultured as micromasses for 4 days in defined media. As described previously, chondrogenesis in stage 23/24 MND cells was significantly enhanced by concentrations of RA of 0.1-1 ng/ml; however, at all earlier stages examined (18 to 22) RA at these concentrations had no significant effect. Higher concentrations of the retinoid inhibited chondrogenesis in MND cultures from all stages tested. Cells of the FNP from all stages displayed no significant change in chondrogenesis below 1 ng/ml RA and a dose dependent inhibition at higher concentrations. Thus RA's promotional effects in the face are not only tissue specific (MND), but also stage-dependent (HH 23/24). The specific effects of RA on matrix production and cell proliferation of stage 23/24 MND and FNP cells was examined by analysis of 35S sulfate, 3H thymidine and 3H proline incorporation. Analysis of 35S sulfate incorporation into sulfated proteoglycans confirmed that concentrations of RA of 0.1-1 ng/ml stimulated cartilage matrix production in MND but not FNP cultures. Above this level of RA, 35S sulfate incorporation was reduced in both. Likewise, 3H proline incorporation into collagenous protein, and to a lesser extent non-collagenous proteins, was stimulated by low levels of RA in MND, but not FNP cultures. Higher concentrations of the retinoid in either MND or FNP cultures did not lower collagen production, undoubtedly due to stimulation of non-chondrogenic cells within the population. This indicates that levels of RA as high as 100 ng/ml cause phenotypic change rather than cell death. This last point is corroborated by the analysis of 3H thymidine uptake in the cultures which was only transiently modified in most. The data indicate that cell proliferation occurred even in the presence of high RA levels.
维甲酸(RA)是一种众所周知的强效致畸剂,可在体内诱发多种面部缺陷,但在低于导致面部缺陷的浓度水平时,RA似乎在正常面部发育中发挥重要作用。在先前的一项研究中,我们证明了RA在体外能够刺激HH阶段23/24鸡下颌(MND)间充质细胞的软骨形成,但对在无血清培养基中培养的额鼻(FNP)间充质细胞没有此作用。本研究通过检测RA对鸡胚早期面部间充质细胞软骨形成的影响以及对23/24阶段细胞增殖和特定细胞外基质大分子合成的影响,进一步拓展了这些研究结果。将MND和FNP细胞作为微团在特定培养基中培养4天。如前所述,0.1 - 1 ng/ml的RA浓度可显著增强23/24阶段MND细胞的软骨形成;然而,在所有检测的早期阶段(18至22阶段),这些浓度的RA没有显著影响。更高浓度的视黄酸抑制了所有测试阶段MND培养物中的软骨形成。在低于1 ng/ml RA时,所有阶段的FNP细胞软骨形成没有显著变化,而在较高浓度时呈现剂量依赖性抑制。因此,RA在面部的促进作用不仅具有组织特异性(MND),还具有阶段依赖性(HH 23/24)。通过分析35S硫酸盐、3H胸腺嘧啶核苷和3H脯氨酸的掺入情况,检测了RA对23/24阶段MND和FNP细胞基质产生和细胞增殖的特定影响。对掺入硫酸化蛋白聚糖中的35S硫酸盐的分析证实,0.1 - 1 ng/ml的RA浓度刺激了MND培养物中软骨基质的产生,但对FNP培养物没有此作用。高于此RA水平,两者中35S硫酸盐的掺入均减少。同样,低水平的RA刺激了MND培养物中3H脯氨酸掺入胶原蛋白,以及在较小程度上掺入非胶原蛋白,但对FNP培养物没有此作用。在MND或FNP培养物中,更高浓度的视黄酸并没有降低胶原蛋白的产生,这无疑是由于刺激了群体中的非软骨形成细胞。这表明高达100 ng/ml的RA水平会导致表型改变而非细胞死亡。这最后一点在对培养物中3H胸腺嘧啶核苷摄取的分析中得到了证实,在大多数情况下,其摄取只是短暂改变。数据表明,即使在高RA水平下也会发生细胞增殖。